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Abstract 
It has been proved that arterial hypertension is not associated exclusively with an 
increase in vascular tone but also with a complex of pathological processes that results in 
cardiovascular pathology and lesions of the target organs. The central and peripheral contours 
of blood pressure regulation are well studied. Nevertheless, despite the presence of two 
regulatory contours the key structure that integrates and controls their function is the 
hypothalamus, in particular its arcuate nucleus. It is proved that the effectiveness of blood 
pressure regulation depends on those neuromodulators and neurohormones that are 
synthesized in the hypothalamus or transported to it. The most important neurohormones in 
the regulation of arterial blood presssure are brain natriuretic peptide, β-endorphin, 
neurotensin and angiotensin II. Equally important factor is the functional state of arcuate 
nucleus neurons, which depends on adequate blood supply, innervation and inter-neuronal 
relationships. The link between the above described processes is nitrogen monoxide system 
(NOS) and its universal messenger – nitric oxide NO. 
The purpose of the work was to determine the nature of the balance of pressor 
(angiotensin II and neurotensin) and depressor (brain natriuretic peptide and β-endorphin) 
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neurohormones in the neurons of the arcuate nucleus of the hypothalamus and the ratio of 
NOS isoforms with hypertension of different etiology. 
Materials and methods. The studies were conducted on 32 mature male Wistar rats 
and 16 male spontaneously hypertensive rats. To study the content of neuropeptides and NOS 
enzyme isoforms, an immunohistochemical method was used, followed by digital image 
processing by Image J. The results that were obtained were calculated using the "Statistica 
11.0" program. 
Conclusions 
1. The same changes of neuropeptides’ content in hypothalamic arcuate nucleus are 
observed in the rats with arterial hypertension which are characterized by a decrease in the 
brain natriuretic peptide, β-endorphin and angiotensin II content with a significant increase in 
neurotensin content regardless of arterial hypertension etiology and pathogenesis. The 
peculiarities of the balance between depressor and pressor substances depend on the 
etiopathogenetic mechanisms – with the endocrine-salt model of arterial hypertension there is 
a significant predominance of depressor neuropeptides (in 4.3 times) whereas in essential 
hypertension this balance is similar to the control. 
2. The changes of the NOS isoform ratio in the arcuate nucleus of hypothalamus are 
unidirectional, both with endocrine-salt model of arterial hypertension and essential 
hypertension – the content of eNOS decreases while nNOS and iNOS content increases. 




To date, pathogenesis of arterial hypertension (AH) is not associated exclusively with 
an increase in vascular tone. It has been proved that a steady increase in blood pressure (BP) 
is accompanied by a complex of pathological processes, namely increase of sympathetic 
nervous system activity, metabolic disorders, hormonal imbalance, insulin resistance and 
rapid progression of atherosclerosis. Above mentioned processes result in cardiovascular 
pathology development with the lesions of target organs [1]. 
It should be noted that the contours of BP regulation are well studied. According to 
classical concepts, they can be divided into central and peripheral. The central mechanisms 
include the cerebral cortex, the limbic system, the hypothalamic nuclei, the supra-segmental 
and segmental centers of the autonomic nervous system. Peripheral contour is presented by 
renin angiotensin aldosterone system, the renal mechanism, in particular, prostaglandins, and 
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a family of natriuretic peptides of the heart, which provide adequate regulation of arterial 
pressure. The key structure that integrates and controls the function of these contours is the 
hypothalamus and its nuclei. The effectiveness of BP regulation and maintenance depends on 
the concordance and coordination of hypothalamic nuclei action with higher and peripheral 
regulatory systems [2, 3, 4]. 
Most of the researchers consider the arcuate nucleus (ARC) of the hypothalamus to be 
an important structure that coordinates and modulates the work of the hypothalamic centers. 
This function is realized due to its topography, variety of receptors on its neurons (NPY1, 
leptin, insulin, corticosteroids, estradiol) and possibility of synthesizing a large number of 
neuropeptides (dopamine, dinorphine, β-endorphine, neuropeptide Y, neurotensin, 
melanostimulating hormone, etc.) [5, 6, 7]. A number of researchers have found that the 
effectiveness of BP regulation mostly depends on those neuromodulators and neurohormones 
that are synthesized in the hypothalamus or transported to it. It has been proved that the most 
significant neurohormones in the regulation of BP are brain natriuretic peptide (BNP), β-
endorphin, neurotensin and angiotensin II [8, 9]. 
Equally important factor that plays a significant role in regulating the activity of 
neurons is their functional state, which depends on adequate blood supply, innervation and 
interneuronal relations, which are provided by adequate microcirculation and neuroglia. 
The link between the above described processes is the system of nitrogen monoxide 
and its universal messenger NO. Currently three isoforms of the nitric oxide synthase (NOS) 
are known: neuronal (nNOS), inducible (iNOS) and endothelial (eNOS) [10]. It has been 
proved that the synthesis of NO and its effect, both quantitatively and topographically, 
depends on the amount and type of the enzyme that generates it. With the predominant 
generation by eNOS improvement of blood supply is expected, nNOS - will stimulate 
neurotrophic processes, while iNOS will trigger local inflammation and cell death [11]. 
Therefore, there is an assumption that the functional activity of the ARC will directly depend 
on the presence, ratio and quantitative characteristics of NOS isoforms in its neurons. 
Whereas the balance of pressor and depressor neurohormones will characterize the state and 
activity of the central – hypothalamic – contour of BP regulation [12]. 
The purpose of the work was to determine the nature of the balance of pressor 
(angiotensin II and neurotensin) and depressor (BNP and β-endorphin) neurohormones and 
the ratio of NOS isoforms in the neurons of the ARC of the hypothalamus with hypertension 
of different etiology. 
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Materials and methods. The studies were carried out on 32 mature male Wistar rats 
and 16 adult male spontaneously hypertensive rats (SHR). Animals that were used in 
experiments were obtained from the kennel of the Veterinary Medicine Association of 
Biomodelservice (Kyiv, Ukraine). All studies were conducted in the autumn-winter period in 
the vivarium of the Zaporizhzhia State Medical University. The animals were at air 
temperature 20-250 С, with a daylight hours 7-00 – 19-00, with free access to food and water 
and a standard diet. 
The experimental part of the study was carried out exactly in accordance with the 
National "General Ethical Principles of Animal Experimentation" (Ukraine, 2001), in 
agreement with the Directive 2010/63EU of the European Parliament and of the Council of 22 
September 2010 on the protection of animals used for scientific purposes. 
Animals were divided into three groups, with two subgroups in each: 
Group 1a was a control group; it consisted of 10 mature Wistar rats. 
Group 1b was an additional control group of 6 adult male Wistar rats. Fivefold 
pressure measurement showed stable indices of BP. Psyst/Pdiast was 110/75 ± 5 mmHg, which 
made it possible to attribute them to a group of normotensive animals. 
Group 2a consisted of 10 mature rats of the SHR line which are considered as a model 
of essential arterial hypertension (EAH). 
Group 2b was an additional group and included 6 mature SHR. BP measurement 
showed steady high figures during all studies Psyst/Pdiast was 165/110 ± 10 mm. Hg. that 
confirmed the development of spontaneous hypertension. 
Rats of 3a and 3b groups were modeled with secondary AH for 30 days by forming a 
daily cortisosteroid imbalance and salt load - endocrine-salt arterial hypertension (ESAH). At 
the beginning of the modeling BP in rats was 110/75 ± 5 mmHg, steady increase of BP was 
reached for 14th day: 160/100 ± 10 mmHg and it remained constantly high until the end of the 
simulation.  
Group 3a was formed from 10 mature Wistar rats to study the ratio of NOS isoforms. 
Group 3b was additional (6 mature Wistar rats), which was formed to study the 
content of neuropeptides in the ARC of the hypothalamus. 
All the rats of additional groups were injected with 120 μg colchicine (SIGMA 
Chemical, USA) diluted in 20 μl of 0.9% NaCl solution. Colchicine was injected into the 
lateral brain ventricle on the 28th day of research 48 hours before removal from the 
experiment [13]. 
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Animals on the 30th day of the simulation were deprived of food from 18-00 and the 
next day from 10-00 they were removed from the experiment by one-stage decapitation under 
anesthesia (sodium thiopental 40 mg/kg intraperitoneally).  
The animals’ brain was placed into the Bouin’s solution for 20 hours (t = 23-250C) 
immediately after the decapitation. After 2 hours of washing out of picric acid in running cold 
water, the brain was dehydrated in ascending concentrations of ethanol (50%-100%) at the 
t=+370C  and then put at liquid paraplast (t= +560С) for 1 hour, and finally it was placed in 
paraplast blocks.  
The frontal serial sections (14 μm) of the brain were made on the rotary microtome 
MICROMHR-360 (Microm, Germany). The histological sections were deparaffinized and 
rehydrated in descending solutions of ethyl alcohol and washed three times for 10 minutes in 
0.1 M phosphate buffer (pH 7.4 ) before the application of the primary antibodies.  
The study of NOS isoform expression of was performed in rats of 1a, 2a and 3a 
groups. Serial histological sections of the hypothalamus were processed by a standard 
immunohistochemical study [14]. 
An immunohistochemical study of neuropeptides (BNP, β-endorphine, angiotensin II, 
and neurotensin) was performed in 1b, 2b, and 3b groups using the procedure described 
before [15, 16]. 
The stereotactic atlas of the rat brain was used for the identification of the ARC 
neurons and further detection of the neuropeptide complex (BNP, β-endorphine, angiotensin 
II, and neurotensin) and the isoform profile of the NOS enzyme in the studied structure [17]. 
The histological sections were examined with ultraviolet microscopy using a high-
power filter 38 NE (Zeiss, Germany) on a microscope of AxioImager-M2 (Zeiss, Germany) 
with a help of highly sensitive video camera AxioCam-5HRm (Zeiss, Germany). The image 
analysis was carried out in semi-automatic mode using the open source Image J (National 
Institutes of Health, USA) software. 
Zones with statistically significant fluorescence were identified while analyzing the 
images in the interactive mode using the “mask”. This method allowed us to determine the 
content of the immunoreactive material (IRM) in the relative units (Uif) to the studied 
neuropeptide, or NOS isoform in the corresponding region of the nucleus, and to distinguish 
the neurons of ARC from other hypothalamic nuclei and blood vessels. 
The number of studied fields of view with masks in the sections of ARC was at least 
170-200 in each series of the experiment. 
 497 
Using the obtained digital data "depressor-pressor coefficient" (KDP) and the "isoform 
ratio of the enzyme NOS" were calculated. 
The "depressor-pressor coefficient" (KDP) was calculated according to the formula: the 
sum of BNP and β-edorphine content was divided by the sum of angiotensin II and 
neurotensin content. The isoform ratio was calculated using the proportion in which the 
content of the eNOS was taken as a unit. 
The calculation of the obtained results was carried out using the program "Statistica 
11.0" (Stat Soft Ins, USA). To compare the indices of groups with normal data distribution, 
the Student t-criterion was used. The data is presented as a mean arithmetic and standard error 
of representativeness of the mean value. The differences were considered to be statistically 
reliable at a value of р<0,05 [18]. 
Results of research and discussion 
In the course of the study it was found that in the rats with developed AH the same 
changes of neuropeptides’ content in ARC are observed: a decrease in the BNP, β-endorphin 
and angiotensin II content  with a significant increase in the neurotensin content regardless of 
AH etiology and pathogenesis (Fig. 1). 
 
Figure 1 - Quantitative characteristic of neuropeptides content in the ARC of the 
hypothalamus. 
 
However, when calculating the depressor-pressor coefficient, significant differences 
were found in the groups of rats with different models of hypertension. Thus, in the EAH 
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model, this parameter (KDP = 2.82) did not differ significantly from the values of control 
group animals (KDP = 2.97) with normal BP. A significant prevalence of depressor 
neuropeptides in 4.3 times (KDP = 4.3), which was associated with a higher content of β-
endorphin, and a lower neurotensin value in the ESAH model if compared with the 
corresponding indice of the EAH group (see Figure 1). 
An analysis of the NOS isoforms content has shown that the development of AH, 
regardless of the AH model, leads to the same changes in the isoform profile. The increase of 
the IRM content both to the nNOS and to the iNOS was noted, at the same time eNOS content 
decreased (Fig. 2). 
 
Figure 2 - Quantitative characterization of the content of ARC in the hypothalamus of 
the endothelial NOS, neuronal NOS and inducible NOS. 
 
Calculation of the NOS enzyme isoforms ratio the demonstrated its features in 
etiologically different AH. In the control group the ratio of eNOS : nNOS : iNOS was 
1:0.7:0.86, in the rats with EAH – 1:1.01:1.06, and the rats with ESAH - 1: 0.98: 1.09. It 
should be noted that hypertension development resulted in a significant increase in the iNOS 
content by 13% in EAH and by 15.5% at ESAH. Other important feature of AH development 
was the increase of nNOS content along with the decrease of the eNOS content (see Figure 2). 
Analysis and discussion of results 
The results of the research demonstrate that AH development leads to to complex and 
diverse changes of both regulatory neuropeptides balance and NOS enzyme isoforms’ profile 
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in the structure of the ARC of the hypothalamus. Similar changes in the content of all three 
NOS isoforms were observed both in EAH and in ESAH: the decrease of the eNOS content in 
the ARC structure was accompanied by a reliable increase in nNOS and iNOS content. The 
revealed peculiarities can be explained by the nature of isoforms’ intracellular 
compartmentalization, their role in regulating neurotrophic and protective functions, and 
changes of isoforms’ genes expression with a steady increase in BP [18]. 
The balance of the constitutive NOS isoforms content in AH was characterized by a 
decrease in eNOS with the increase of nNOS that can be related to a number of factors. In the 
experiment of Gerasimova A.S., it was found that inhibition of nNOS activity is accompanied 
by increase in vasopressin concentration, whereas the reverse effect causes its decrease and, 
accordingly, decreases blood circulating volume and total peripheral vascular resistance [19]. 
Thus, the described effect can be considered as an important mechanism of elevated BP 
correction. The decrease in the eNOS content is associated by the most of researchers both 
with the decrease of gene expression and the influence of endogenous inhibitors such as 
asymmetric dimethylarginine, the content of which largely increases in blood plasma in 
cardiovascular disease [20]. The high vulnerability of eNOS to the inhibiting influence is 
related to the features of its subcellular localization. It was found that the granules of the 
enzyme are located predominantly in the cell membrane, the Golgi apparatus, the nucleus and 
the mitochondria [20]. In contrast, nNOS is represented in the cytoplasm, sarcolemma, and 
endoplasmic reticulum of the cell [21]. 
The established fact of the high iNOS content confirm the results of numerous 
researchers which have proved that NO synthesized by iNOS is involved in inflammation and 
oxidative stress because hypertension, both in subjects with obesity and with cardiovascular 
diseases, usually includes an inflammatory process. Moreover, there are reports of an initially 
abnormal increase of the iNOS expression in AH [21]. However, there are alternative versions 
of the enhanced expression of iNOS. It is believed that it can play a physiological protective 
role in BP increase by modulating the production of cyclooxygenase and thrombocytes’ 
regulating eicosanoids [21]. 
The changes of the depressor-pressor relationships in the ARC of the hypothalamus in 
AH were unidirectional but with specific features for EAH and ESAH. It was revealed that 
depressor peptides (BNP and β-endorphin) and angiotensin II content decreased while 
neurotesin content increased (see Fig. 1). Taking into account the established fact of eNOS 
content decrease in the ARC, it is possible to suppose a decrease in the transport of these 
neuropeptides to ARC structure from other parts of the brain. While the increase in 
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neurotensin content that is synthesized in the neurons of ARC can be related on the one side 
to its genetically determined excessive abnormal synthesis in the SHR line rats and on the 
other side it can be the component of BP central regulation in the rats with ESAH. Our 
supposition is related to the established fact of dose-dependent effect of neurotensin with 
intraventricular administration. In Samers' work, it was shown that high doses of neurotensin 
(more than 2 mg) contributed to BP increase, while as sub-threshold doses, on the contrary, 
reduced BP [22, 23]. Genetically determined AH in the rats of the SHR line is probably 
associated with an abnormally high neurotensin level, whereas in AH, which was formed as a 
result of endocrine pathology, slight increase of neurotensin to 10% caused the reverse effect 
– a decrease in BP, working as a compensation mechanism. 
Conclusions 
1. The same of changes of neuropeptides’ content in ARC are observed in the rats with 
developed AH which are characterized by a decrease in the BNP, β-endorphin and 
angiotensin II content  with a significant increase in the neurotensin content regardless of AH 
etiology and pathogenesis. The peculiarities of the balance between pressor and depressor 
neuropeptides depend on the etiopathogenetic mechanisms – with ESAH there is a significant 
predominance of depressor neuropeptides content (in 4.3 times), whereas in the EAH this 
balance is similar to the control. 
2. The changes of the NOS isoforms’ profile in the ARC of the hypothalamus are 
unidirectional, both with ESAH and EAH – the  content of eNOS decreases while nNOS and 
iNOS content increases. 
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